CD16 (alpha unit, short)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6faed/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6faed/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6faec/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6faec/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6faeb/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6faeb/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6faea/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6faea/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae9/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae9/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae8/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae8/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae7/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae7/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae6/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae6/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae5/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae5/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae4/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae4/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae3/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae3/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae2/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae2/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae1/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae1/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fae0/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fae0/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fadf/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fadf/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fade/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fade/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fadd/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fadd/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fadc/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fadc/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fadb/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fadb/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fada/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fada/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad9/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad9/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad8/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad8/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad7/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad7/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad6/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad6/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad5/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad5/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad4/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad4/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad3/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad3/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad2/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad2/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad1/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad1/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fad0/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fad0/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6facf/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6facf/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6face/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6face/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6facd/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6facd/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6facc/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6facc/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6facb/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6facb/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6faca/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6faca/cd16-alpha-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331ec1d8c4400021f6fac9/cd16-alpha-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331ec1d8c4400021f6fac9/cd16-alpha-unit-short.png"}]
Keywords
CD16,Fc receptor,Fc region,FcγRIII,FCGR3A,α-chain,alpha,alpha chain,α chain,alpha-unit,Ig-like,Ig like,immunoglobin-like,alpha unit,short,CD16